On March 30th, al-Shabaab terrorists issued a statement rejecting the Oxford-AstraZeneca vaccine for Somalia.
They cited its ‘ineffective and adverse’ side effects.
A statement released by the group warned Somalis against administering the AstraZeneca vaccine saying it is “deadly and unsafe.”
The statement linked the recent move by dozens of countries including European nations like Germany, Italy and France to reject the vaccine because of its side effects.
“These are countries with far better medical resources than the apostate Somali regime, which doesn’t even have qualified medical personnel or laboratories to assess the efficiency, safety or performance of the vaccine,” the statement read.
“Do now allow your children and family members to be used as guinea pigs in the race to develop a potent vaccine for the coronavirus pandemic. Do not allow your family to be used as subjects in the experimentation of the safety of the AstraZeneca vaccine at a time when a countless number of people have died, and hundreds of others have developed severe adverse reactions, including the formation of blood clots, as a result of administering the vaccine,” the statement continued.
Experts probing links between the AstraZeneca coronavirus vaccine and blood clots have found no specific risk factors, including age, but are carrying out further analysis, the EU’s drug regulator said on March 31st.
The European Medicines Agency (EMA) said however that its safety committee expected to issue an “updated recommendation” on the controversial vaccine.
AstraZeneca’s vaccine has got so much bad publicity due to its alleged adverse side effect that it’s even changing the name of the vaccine.
The British-Swedish pharmaceutical AstraZeneca announced that the COVID-19 vaccine, in conjunction with the British University of Oxford, has been renamed Vaxzevria.
The name change was approved on March 25 following a request from the company and was announced on the website of the European Medicines Agency (EMA) and that of the Swedish National Medicines Agency (Läkemedelsverket).
The new name does not imply a change in the formula of the vaccine, according to the Läkemedelsverket, but there will be a new labeling and packaging of the drug.
For its part, the EMA recalled that the Vaxzevria vaccine is safe in people over 18 years of age, but that it has reduced its effectiveness from 79 to 76%.
The name change is just a hope that most people don’t pay attention and would simply get vaccinated with AstraZeneca’s product, without questioning it further.